But the high rate of HIV infections, despite gold-standard care in the trial, is a call to action for improved HIV prevention and contraceptive choice for women that addresses social and structural factors influencing behavior.
A clinical trial is exploring a potential link between certain contraceptives and HIV acquisition. Careful dissemination of the findings is vital to keeping women safe and family planning momentum going, says CCP’s Susan Krenn.
Receive the latest news and updates, tools, events and job postings in your inbox every month
Sign up to our monthly newsletter
